BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 556 filers reported holding BIO-TECHNE CORP in Q3 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $495,515 | -9.1% | 6,679 | +1.5% | 0.02% | -38.5% |
Q4 2022 | $545,350 | +21.2% | 6,580 | +315.7% | 0.03% | +85.7% |
Q3 2022 | $450,000 | -15.1% | 1,583 | +4.0% | 0.01% | -6.7% |
Q2 2022 | $530,000 | -34.2% | 1,522 | -16.5% | 0.02% | -6.2% |
Q1 2022 | $806,000 | -11.4% | 1,823 | +1.9% | 0.02% | -11.1% |
Q4 2021 | $910,000 | +8.9% | 1,789 | +4.9% | 0.02% | +12.5% |
Q3 2021 | $836,000 | +18.8% | 1,705 | +8.4% | 0.02% | +45.5% |
Q2 2021 | $704,000 | -65.8% | 1,573 | -71.5% | 0.01% | -70.3% |
Q1 2021 | $2,058,000 | +343.5% | 5,510 | +276.1% | 0.04% | +270.0% |
Q4 2020 | $464,000 | +40.6% | 1,465 | +9.6% | 0.01% | 0.0% |
Q3 2020 | $330,000 | +2.5% | 1,337 | +5.3% | 0.01% | -9.1% |
Q2 2020 | $322,000 | +22.0% | 1,270 | -8.2% | 0.01% | -8.3% |
Q1 2020 | $264,000 | -2.2% | 1,383 | +11.3% | 0.01% | +33.3% |
Q4 2019 | $270,000 | +42.1% | 1,243 | +29.3% | 0.01% | +28.6% |
Q3 2019 | $190,000 | -5.9% | 961 | -1.7% | 0.01% | +16.7% |
Q2 2019 | $202,000 | +6.9% | 978 | +2.9% | 0.01% | -33.3% |
Q1 2019 | $189,000 | +50.0% | 950 | +9.3% | 0.01% | +50.0% |
Q4 2018 | $126,000 | -16.0% | 869 | +18.1% | 0.01% | 0.0% |
Q3 2018 | $150,000 | -81.8% | 736 | +11.5% | 0.01% | -89.8% |
Q2 2018 | $824,000 | +724.0% | 660 | -4.6% | 0.06% | +883.3% |
Q1 2018 | $100,000 | +25.0% | 692 | +14.2% | 0.01% | 0.0% |
Q4 2017 | $80,000 | +27.0% | 606 | +16.5% | 0.01% | +20.0% |
Q3 2017 | $63,000 | +12.5% | 520 | +9.0% | 0.01% | 0.0% |
Q2 2017 | $56,000 | +86.7% | 477 | +62.8% | 0.01% | -77.3% |
Q1 2016 | $30,000 | – | 293 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ownership Capital B.V. | 972,263 | $308,742,000 | 4.35% |
Sandhill Capital Partners LLC | 138,864 | $44,096,000 | 4.03% |
STONE RUN CAPITAL, LLC | 27,350 | $8,685,000 | 3.45% |
DF DENT & CO INC | 925,823 | $293,995,000 | 3.42% |
Brown Capital Management | 1,498,233 | $475,764,000 | 3.29% |
MAIRS & POWER INC | 848,081 | $269,308,000 | 2.99% |
Summit Creek Advisors LLC | 64,179 | $20,380,000 | 2.62% |
GENEVA CAPITAL MANAGEMENT LLC | 402,958 | $127,959,000 | 2.17% |
Aristotle Atlantic Partners, LLC | 86,993 | $27,625,000 | 2.13% |
CROWN ADVISORS MANAGEMENT, INC. | 8,000 | $2,540,000 | 1.82% |